Empower Advisory Group
EW icon

Empower Advisory Group’s Edwards Lifesciences EW Stock Holding History

Empower Advisory Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.4M Buy
866,719
+34,697
+4% +$2.86M 0.18% 112
2025
Q4 		$70.9M Sell
832,022
-130,682
-14% -$10.7M 0.19% 103
2025
Q3 		$74.9M Buy
962,704
+12,796
+1% +$1,000K 0.21% 96
2025
Q2 		$74.3M Buy
949,908
+34,737
+4% +$2.59M 0.22% 97
2025
Q1 		$66.3M Buy
915,171
+139,608
+18% +$9.99M 0.22% 99
2024
Q4 		$57.4M Buy
775,563
+69,685
+10% +$4.88M 0.19% 107
2024
Q3 		$46.6M Buy
705,878
+144,857
+26% +$10.5M 0.16% 112
2024
Q2 		$51.8M Sell
561,021
-9,702
-2% -$859K 0.19% 112
2024
Q1 		$54.5M Buy
570,723
+40,579
+8% +$3.41M 0.2% 110
2023
Q4 		$40.4M Buy
530,144
+65,497
+14% +$4.56M 0.16% 115
2023
Q3 		$32.2M Sell
464,647
-161,237
-26% -$13M 0.14% 118
2023
Q2 		$59M Buy
625,884
+13,819
+2% +$1.2M 0.25% 91
2023
Q1 		$50.3M Buy
+612,065
New +$48.1M 0.23% 106

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Empower Advisory Group's EW Position: Q1 2026 in Review

Empower Advisory Group increased its Edwards Lifesciences (EW) stake by 4.2% in Q1 2026, buying an estimated $2.86M and bringing the position to 866,719 shares worth $69.4M. The position accounts for 0.18% of the portfolio, ranked #112.

Empower Advisory Group first reported a position in EW in Q1 2023 and has held it in 13 quarters since. The position peaked at $74.9M in Q3 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Empower Advisory Group held 866,719 shares of Edwards Lifesciences worth $69.4M as of Q1 2026.
  • Empower Advisory Group bought 34,697 Edwards Lifesciences shares in Q1 2026, an estimated $2.86M.
  • Edwards Lifesciences made up 0.18% of Empower Advisory Group's portfolio in Q1 2026, its #112 holding.
  • Empower Advisory Group first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 13 quarters since.
  • Empower Advisory Group's Edwards Lifesciences position peaked at $74.9M in Q3 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.